Receptos, Inc. | TalkMarkets | Page 1
No data available
No data available

Latest Articles

About This Stock More About This Stock
Insider Trading Report Edition 230: Notable Buys And Sales
Article By: Asif Suria
Sunday, November 16, 2014 4:19 PM EDT
Insider buying decreased last week with insiders buying $73.83 million of stock compared to $90.85 million in the week prior. Selling also decreased with insiders selling $1.67 billion of stock last week compared to $2.18 billion in the week prior.
In this article: CHK, HAS, LF, NMFC, P, SCHW, X, TRUE, PSEC, REGN, FNFG, MDRX, MEMP, NOW, RCPT, TPUB
Read
Active Stocks: Columbia Laboratories, Neurometrix, Cynosure, Receptos, Bristol-Myers
Article By: BioMedReports
Tuesday, October 28, 2014 5:38 PM EDT
U.S. stocks climbed in afternoon trading on Tuesday, following stronger-than-expected earnings and an upbeat consumer confidence reading.
In this article: BMY, CBRX, CYNO, NURO, RCPT
Read
Chart Of The Day - Receptos (RCPT)
Article By: Jim Van Meerten
Sunday, January 26, 2014 10:38 PM EDT
Receptos, Inc. is a biopharmaceutical company. It develops therapeutic for the treatment of immune and metabolic diseases. It hit an all time high on Friday.
In this article: RCPT
Read

Latest Tweets for $RCPT

No tweets yet!

PARTNER HEADLINES